Cite
APA Citation
McKay, R. R., De Velasco, G., Werner, L., Bellmunt, J., Harshman, L., Sweeney, C., Rosenberg, J. E., Hirsch, M., Signoretti, S., Van Allen, E. M., Walsh, M., Vaishampayan, U., McDermott, D. F., & Choueiri, T. K. (2016). a phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor‐targeted therapies. Cancer, 122(15), 2389–2398. http://access.bl.uk/ark:/81055/vdc_100034717875.0x000062